Listing 1 - 2 of 2 |
Sort by
|
Choose an application
"The 2009 H1N1 vaccination campaign was one of the largest public health campaigns in U.S. history, vaccinating one-quarter of the population in the first three months. The Institute of Medicine held three workshops in Raleigh, NC; Austin, TX; and Seattle, WA to learn from participants' experiences during the campaign and improve future emergency vaccination programs."
H1N1 influenza --- Influenza vaccines --- Vaccination --- Influenza A virus --- Viral Vaccines --- Immunization Programs --- North America --- Orthomyxoviridae Infections --- Respiratory Tract Infections --- Vaccines --- Immunization --- Immunotherapy, Active --- Respiratory Tract Diseases --- Preventive Health Services --- RNA Virus Infections --- Americas --- Influenzavirus A --- Virus Diseases --- Biological Products --- Health Services --- Orthomyxoviridae --- Primary Prevention --- Diseases --- Geographic Locations --- Community Health Services --- Communicable Disease Control --- Influenza A Virus, H1N1 Subtype --- Mass Vaccination --- United States --- Influenza Vaccines --- Influenza, Human --- Geographicals --- Immunotherapy --- Complex Mixtures --- RNA Viruses --- Public Health Practice --- Health Care Facilities, Manpower, and Services --- Immunologic Techniques --- Public Health --- Vertebrate Viruses --- Health Care --- Immunomodulation --- Chemicals and Drugs --- Investigative Techniques --- Viruses --- Analytical, Diagnostic and Therapeutic Techniques and Equipment --- Biological Therapy --- Environment and Public Health --- Organisms --- Therapeutics --- Health & Biological Sciences --- Communicable Diseases --- Prevention --- Vaccination. --- H1N1 flu --- Novel H1N1 flu --- Novel H1N1 influenza --- Novel influenza A --- Swine flu (H1N1) --- Swine influenza (H1N1) --- Swine influenza
Choose an application
"In March and early April 2009, a new, swine-origin 2009-H1N1 influenza A virus emerged in Mexico and the United States. During the first few weeks of surveillance, the virus spread by human-to-human transmission worldwide to over 30 countries. On June 11, 2009, the World Health Organization (WHO) raised the worldwide pandemic alert level to Phase 6 in response to the ongoing global spread of the novel influenza A (H1N1) virus. By October 30, 2009, the H1N1 influenza A had spread to 191 countries and resulted in 5,700 fatalities. A national emergency was declared in the United States and the swine flu joined SARS and the avian flu as pandemics of the 21st century. Vaccination is currently available, but in limited supply, and with a 60 percent effectiveness rate against the virus. The story of how this new influenza virus spread out of Mexico to other parts of North America and then on to Europe, the Far East, and now Australia and the Pacific Rim countries has its origins in the global interconnectedness of travel, trade, and tourism. Given the rapid spread of the virus, the international scientific, public health, security, and policy communities had to mobilize quickly to characterize this unique virus and address its potential effects. The World Health Organization and Centers for Disease Control have played critical roles in the surveillance, detection and responses to the H1N1 virus. The Domestic and International Impacts of the 2009-H1N1 Influenza A Pandemic: Global Challenges, Global Solutions aimed to examine the evolutionary origins of the H1N1 virus and evaluate its potential public health and socioeconomic consequences, while monitoring and mitigating the impact of a fast-moving pandemic. The rapporteurs for this workshop reported on the need for increased and geographically robust global influenza vaccine production capacities; enhanced and sustained interpandemic demand for seasonal influenza vaccines; clear "triggers" for pandemic alert levels; and accelerated research collaboration on new vaccine manufacturing techniques. This book will be an essential guide for healthcare professionals, policymakers, drug manufacturers and investigators."--executive summary.
H1N1 influenza --- Influenza --- Epidemics --- Communicable diseases --- Animals as carriers of disease --- World health --- Public Health --- Health --- Publication Formats --- Influenza A virus --- Respiratory Tract Infections --- Orthomyxoviridae Infections --- Disease Transmission, Infectious --- Influenzavirus A --- Population Characteristics --- Respiratory Tract Diseases --- Medicine --- RNA Virus Infections --- Environment and Public Health --- Publication Characteristics --- Virus Diseases --- Health Care --- Diseases --- Orthomyxoviridae --- Health Occupations --- RNA Viruses --- Disciplines and Occupations --- Vertebrate Viruses --- Viruses --- Organisms --- Influenza A Virus, H1N1 Subtype --- Epidemiology --- Congresses --- Disease Outbreaks --- World Health --- Disease Vectors --- Influenza, Human --- Health & Biological Sciences --- Communicable Diseases --- Prevention --- Transmission --- H1N1 influenza. --- Epidemics. --- Animals as carriers of disease. --- World health. --- Prevention. --- Epidemiology. --- Transmission. --- Disease outbreaks --- Outbreaks of disease --- Pestilences --- Flu --- Flu, Respiratory --- Grippe --- Respiratory flu --- H1N1 flu --- Novel H1N1 flu --- Novel H1N1 influenza --- Novel influenza A --- Swine flu (H1N1) --- Swine influenza (H1N1) --- Global health --- International health --- Carriers of disease --- Disease vectors --- Vectors of disease --- Communicable disease transmission --- Disease transmission --- Germs, Spread of --- Spread of communicable diseases --- Spread of germs --- Transmission of diseases --- Outbreaks --- Respiratory infections --- Virus diseases --- Swine influenza --- Public health --- Medical geography --- Zoology, Medical --- Zoonoses --- International cooperation --- Pandemics
Listing 1 - 2 of 2 |
Sort by
|